Received Dec 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y010656 | — |
no adverse event; called to report TE; This spontaneous report was received from an Other health professional and refers to an 11-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-May-2025, the patient started therapy with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (lot #Y010656, expiration date: 29-Nov-2026) 0.5 mL, route of administration was not provided. The vaccine underwent temperature excursion (Temperature 8.8 C for 1 minute). There was no previous temperature excursion. No adverse event was reported.